GRANULOCYTE CHEMOTACTIC PROTEIN 2 VARIANT

摘要

The present invention provides a polynucleotide which identifies and encodes a novel human granulocyte chemotactic protein 2 variant (NGCP). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding NGCP. The invention also provides for the production and use of substantially purified NGCP in pharmaceutical compositions to stop cell division in cancerous cells. The invention also describes diagnostic assays which utilize the polynucleotide to hybridize with the transcripts encoding NGCP and anti-NGCP antibodies which specifically bind to NGCP.